These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30244085)

  • 21. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.
    Wang C; Liu B; Xu X; Zhuang B; Li H; Yin J; Cong M; Xu W; Lu A
    Oncotarget; 2016 Feb; 7(7):8360-72. PubMed ID: 26840019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
    Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
    Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
    Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
    Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.
    Tang B; Tang F; Wang Z; Qi G; Liang X; Li B; Yuan S; Liu J; Yu S; He S
    Int J Nanomedicine; 2016; 11():6401-6420. PubMed ID: 27942213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple-Coated PLGA Nanoparticles Loading Triptolide Attenuate Injury of a Cellular Model of Alzheimer's Disease.
    Jia L; Nie XQ; Ji HM; Yuan ZX; Li RS
    Biomed Res Int; 2021; 2021():8825640. PubMed ID: 33708996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release.
    Kong C; Li Y; Liu Z; Ye J; Wang Z; Zhang L; Kong W; Liu H; Liu C; Pang H; Hu Z; Gao J; Qian F
    ACS Nano; 2019 Apr; 13(4):4049-4063. PubMed ID: 30912923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment.
    Wu YZ; Chen WY; Zeng Y; Ji QL; Yang Y; Guo XL; Wang X
    Pharm Res; 2024 Jul; 41(7):1493-1505. PubMed ID: 38918308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo evaluation of Triptolide-loaded pluronic P105 polymeric micelles.
    Li H; Wen XS; Di W
    Arzneimittelforschung; 2012 Jul; 62(7):340-4. PubMed ID: 22588630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
    Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
    Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide.
    Tian T; Song Y; Li K; Sun Y; Wang Q
    Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.
    Li Z; Yang G; Han L; Wang R; Gong C; Yuan Y
    J Nanobiotechnology; 2021 Nov; 19(1):360. PubMed ID: 34749742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo.
    Li Y; Hu S
    Panminerva Med; 2014 Sep; 56(3):211-20. PubMed ID: 24352031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
    Li M; Wang Y; Jiang S; Gao Y; Zhang W; Hu S; Cheng X; Zhang C; Sun P; Ke W; Wang G; Song Z; Zhang Y; Zheng QC
    Nanomedicine (Lond); 2020 Jan; 15(2):145-161. PubMed ID: 31782335
    [No Abstract]   [Full Text] [Related]  

  • 35. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.
    Mei Z; Li X; Wu Q; Hu S; Yang X
    Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
    Anter HM; Aman RM; Othman DIA; Elamin KM; Hashim IIA; Meshali MM
    Int J Pharm; 2023 Jan; 631():122536. PubMed ID: 36572262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.
    Zhu J; Wang H; Chen F; Lv H; Xu Z; Fu J; Hou Y; Xu Y; Pi J
    Toxicol Appl Pharmacol; 2018 Nov; 358():1-9. PubMed ID: 30196066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.
    Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q
    Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide loaded solid lipid nanoparticle hydrogel for topical application.
    Mei Z; Wu Q; Hu S; Li X; Yang X
    Drug Dev Ind Pharm; 2005 Jan; 31(2):161-8. PubMed ID: 15773283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.